meitshel

CMRX nice bottom play very good risk reward ratio

做多
meitshel 已更新   
NASDAQ:CMRX   Chimerix, Inc.
i like this set up due to risk reward ratio

09/23/2018
Phase 1 data due 23-26 September 2018 at European Society for Clinical Virology.
交易结束:到达止损
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。